GlassScriptPhysician profile
Marcus J Duval
NPI 1922625714
$5,259.87
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $257 · 2021: $2,263 · 2022: $1,349 · 2023: $1,299 · 2024: $91.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814 · Travel and Lodging: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $813.82 |
| Travel and Lodging | $576.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $1,200.00 | 2021 | |
| Stryker Corporation | $792.10 | 2021-2023 | Variax, Sonicanchor, N/A |
| Smith+Nephew, INC. | $640.80 | 2020-2023 | Versajet |
| Treace Medical Concepts, INC. | $634.70 | 2023-2024 | |
| Bioventus LLC | $445.35 | 2021-2022 | |
| Kerecis Limited | $337.53 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $250.26 | 2021-2022 | |
| Kci USA, INC. | $198.89 | 2020-2022 | |
| Aroa Biosurgery Incorporated | $191.58 | 2022 | |
| Alexion Pharmaceuticals, INC. | $149.94 | 2022-2023 | Strensiq |
| Convatec INC. | $123.96 | 2023 | |
| Abbvie INC. | $119.70 | 2022 | |
| Zimmer Biomet Holdings, INC. | $58.64 | 2020-2021 | |
| Bone Support INC. | $29.07 | 2022 | |
| Averitas Pharma INC. | $24.65 | 2023 | Qutenza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $19.88 | 2022 | |
| Metric Medical Devices, INC. | $16.66 | 2023 | Super Scaffold, Super Staple |
| Paragon 28, INC. | $14.30 | 2023 | Phantom Intramedullary Nail |
| Globus Medical, INC. | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Duval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.